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Literature Review; The Effects of Lithium on the Kidney 
Since its isolation in the mineral petalite in 1817, 
salts of the element lithium have been utilized by the med¬ 
ical profession with varying degrees of enthusiasm in the 
treatments of diverse clinical disorders. Originally en¬ 
joying only sporadic popularity as a uric acid solvent in 
the treatment of gouty arthritis and rheumatism (145), its 
first widespread clinical application was as a taste substi¬ 
tute for sodium chloride in the treatment of fluid overload 
states (127). However, a series of reports in the early 1950' 
of deaths due to lithium overdose in these conditions (16,48, 
50,84) ultimately put an end to this therapeutic use. In 
1949 an observation made in Australia (10) suggesting that 
lithium might have a beneficial effect in the treatment of 
mania led to renewed interest in its pharmacotherapeutics. 
In the subsequent two decades lithium has been shown to be 
efficacious in the treatment of affective disorders (22,40, 
46,76,108,110) and had enjoyed widespread popularity in this 
area. In accord with this extensive clinical usage, there 
has grown an impressive list of lithium-induced side effects 
(20,84,111,112) unrelated to its psychotropic effect. Cer¬ 
tain of these effects have been of tlecided nephrologic inter¬ 
est, and are the impetus for the studies herein described. It 
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is the purpose of this introduction to review what is present¬ 
ly known of the renal and cellular effects of lithium, in an 
effort to interpret the present experiments. 
1. ilenal Excretion of Lithium 
It has been known from the earliest experimental efforts 
(45,66) and reaffirmed in recent studies (63,88,99,128,132) 
that at least 95% of lithium ingested in both experimental 
animals and man is excreted by the renal route. Lithium re¬ 
mains unbound to plasma proteins (35,128), and is, hence free¬ 
ly filterable at the glomerulus. Normally in humans from one- 
third to two-thirds of a moderate (27-50 meq./70kg.) acute or¬ 
al dose of either lithium carbonate or chloride is eliminated 
in the urine in the first day (30,88,132), with almost complete 
excretion within one (96) to two weeks (132). Human clearance 
rates have been estimated at about 15-30 ml./min. (Ill), cor¬ 
responding to a CLj_/CQr ratio of about .2 (129,130,131). The 
latter figure was derived from a single seven hour clearance 
experiment in six healthy human volunteers without dietary re¬ 
strictions who had taken an acute oral dose of lithium (16.2 meq.) 
ten hours before urinary collection. It represents the only 
documented value for human urinary clearance of lithium. Cor¬ 
roborative studies in the dog (35,99) and the rat (107) demon¬ 
strated clearance ratios of between .2 and .4, independent of 
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serum lithium concentrations for values greater than 1 meq./L. 
Below this value the latter study suggested that clearance ra¬ 
tios become inversely proportional to serum lithium concentra¬ 
tions, approaching unity as serum lithium concentration ap¬ 
proaches zero. 
Lithium clearance ratios in the rat have also been shown 
to vary with net sodium excretion (107), with higher sodium 
excretion causing higher lithium clearance. Additional evi¬ 
dence from human studies (130) suggests that lithium clear¬ 
ance increases when sodium intake is augmented over long per¬ 
iods of time. (Such an increase was not, however, able to be 
demonstrated with acute oral saline loading.) These phenomena 
may be a partial explanation for the findings of previous stud¬ 
ies which suggest 1) that dogs and humans seem more susceptible 
to the toxic effects of lithium when sodium intake is restrict¬ 
ed (16,48,50,99,125,127) and 2) that lithium treated rats fed 
low sodium diets demonstrate chronically higher plasma lithi¬ 
um levels than those fed high sodium diets (106). 
An excretion fraction ranging between 20 and 40% of fil¬ 
tered lithium in the whole kidney is similar to the excretion 
fraction of sodium from the proximal tubule in both the rat 
(47,134,142) and the dog and man (138). This, coupled with 
the evidence suggesting that tubular rejection of lithium oc¬ 
curs with sodium loading, a phenomenon similar to the tubular 
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rejection of sodium which occurs with acute saline infusion 
(18,25), has prompted certain investigators (131) to hypoth¬ 
esize that lithium is resorbed proximally in a quantitatively 
similar fashion to sodium, with little distal tubular reab¬ 
sorption. Such a conclusion is supported by human experi¬ 
ments (130) which indicate that fractional lithium resorp¬ 
tion is unaffected by administration of thiazides, ethacryn- 
ic acid, and spironolactone in doses sufficient to produce 
a 2-3 fold increase in sodium excretion, (presumably by 
causing tubular rejection of sodium at various distal sites) 
(114), and by experiments (130) which indicate enhanced tu¬ 
bular rejection of lithium under conditions of urea or bi¬ 
carbonate diuresis, both of which are known to diminish prox¬ 
imal tubular sodium reabsorption. 
There is evidence in older dog clearance experiments (35), 
however, in which administration of mercurial diuretics (whose 
presumed site of action is in the proximal tubule (114) ) in¬ 
duced no change in lithium clearance ratios, which cast's some 
doubt on an exclusive proximal resorptive mechanism. Subse¬ 
quent evidence from stop-flow experiments in dogs (62) has im¬ 
plicated some distal lithium resorption, possibly in exchange 
for potassium secretion (although previous work (35) demon¬ 
strated no effect of potassium loading on lithium excretion 
patterns). There has also been the observation from tissue 
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analyses experiments in dogs (123) and rats (34) that there 
is a 2-3 fold corticomedullary gradient for lithium estab¬ 
lished during periods of lithium loading, suggesting lithium 
resorption distal to the terminal end of the proximal tubule. 
Finally, there is a recent report of triameterine induced 
lithium diuresis in humans (4), which suggest that lithium 
may be handled at least in part at aldosterone-insensitive 
distal tubular resorptive site. Thus, while the weight of 
evidence favors a predominant proximal resorptive site for 
lithium, the existence of distal tubular lithium resorption 
has not been ruled out. 
11. clenal Cellular Transport of Lithium 
Because of variation in the clearance of lithium with 
sodium excretion (vide supra) it was postulated in the older 
literature that lithium may in some way compete with sodium 
for tubular- resorption (107). Support for this hypothesis 
is found in studies of the relationship between lithium 
and sodium transport found in other cellular systems. Thus, 
it was demonstrated as early as 1902 (92) and reaffirmed in 
innumerable subsequent experiments (11,19,39,53,59,64) that 
lithium was unique in its ability to substitute for extra¬ 
cellular sodium in supporting both resting and action cell 
potentials. Lithium was subsequently shown to compete with 

-6- 
sodiam for entry into red blood cells (56,122) and mucosal 
entry into toad bladder cells (36). Lithium is also capable 
of replacing sodium (and potassium) in stimulating various 
extracts of sodium-potassium ATPase (116,117,118,139,140,141), 
(an enzyme felt to be important in active transport of sodium 
across the peritubular membrane of the renal cell (65) ) and 
to inhibit active sodium transport out of red cells, possibly 
through interaction with this enzyme (67). Lithium transport 
in toad bladder has also been shown to be partially ouabain 
sensitive, a characteristic shared with sodium ion in this 
preparation (57). Thus there is indirect evidence to suggest 
that lithium may be transported by the same mechanism which 
transports sodium at the cellular level. Such an assumption, 
however, concedes that lithium, like sodium, is actively trans¬ 
ported at the cellular level. Active transport of lithium 
has been directly demonstrated in only one study (147), in 
which it was reported to be transported across a toad bladder 
preparation against an electrochemical gradient. In contra¬ 
distinction to this data is more recent toad bladder data (57) 
suggesting that lithium is unable to cross an unfavorable ener¬ 
gy barrier of 460 cal./eq. In addition, numerous studies from 
work in red cell (32,68,77,78) and kidney slice (17,69) systems 
suggest that lithium can neither be transported actively into 
or out of the cell. Lithium has, rather, been shown to move 
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passively through these cellular membranes, with a rate con¬ 
stant similar to the passive rate constants for sodium and po¬ 
tassium movement (55,77) (which is 10 to 25 time slower than 
the active efflux rate constant for sodium (67,68)),and to 
maintain unaltered its own efflux rate in both red (68) and 
kidney (69) cells when active sodium-potassium exchange was 
inhibited by potassium-free medium, or ouabain, respectively. 
Such data make it unlikely that lithium can be transported 
by a sodium transport system which relies on active pumping 
of the ion out of the cell. 
In summary, then, present evidence indicates that lith¬ 
ium cannot be transported against an electrochemical gradient 
either out of the cell or across an epithelial membrane; how¬ 
ever it does share other transport-related characteristics 
with sodium. From this position, it is difficult to imagine 
that lithium is transported in the tubule by a mechanism sim¬ 
ilar to that postulated for sodium, which, as presently con¬ 
ceived by some (93), relies on active transport of sodium 
from peritubular surface of the renal cell, with subsequent 
passive transfer of tubular sodium through the cell. One 
rather may favor the resoprtive mechanism proposed by Giebisch 
(41,42) wherein sodium is actively resorbed by a peritubular 
pump through both intracellular and extracellular channels 
(the tight junctions of the proximal tubule), with other ions 
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(including lithium) and water following passively through the 
latter. Such a proposition rids one of the necessity of ex¬ 
plaining how lithium would be extruded from the renal cell 
once it enters it. Or one might be tempted to hypothesize 
that lithium is transported by the ouabain-insensitive, peri¬ 
tubular ion transport pump,proposed by Kleinzeller (69) to 
explain isosmotic shifts of ions (lithium included) and water 
in ouabain-inhibited kidney cortex cells. This latter possi¬ 
bility does not require pumping of cellular lithium against 
a peritubular gradient. until more direct work is done on 
renal tubular transport of the lithium, it is impossible to 
do more than conjecture about these and other plausible mech¬ 
anisms for renal lithium resorption. 
Ill. Effects of Lithium on kenal Function 
There remain to be discussed a number of nephrologic 
effects of lithium which may represent pharmacologic effects 
of the ion on tubular function rather than by-products of 
its own renal handling. It has been noted in many studies 
(3,63,87,132,133) that chronic lithium ingestion in humans 
causes altered patterns of urinary sodium excretion, with 
abnormal urinary sodium loss on the first day being followed 
by net lithium retention on subsequent days (the longest ex¬ 
periment was one week in duration). In an additional study (23) 
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nine out of nine patients with no predisposing causes devel¬ 
oped pretibial edema shortly after lithium carbonate therapy 
was begun (although no net sodium retention could be documented 
by urinary sodium determinations). These patients became asymp¬ 
tomatic after lithium therapy was discontinued. Balance esti¬ 
mates in chronic dog (99) and rat (106) experiments have failed 
to show similar retentive patterns, and, in fact, indicated 
chronic urinary sodium loss shortly after parenteral lithium 
administration was begun. However, both dogs and rats at this 
time were already showing symptoms of renal toxicity (see be¬ 
low) and results, therefore, are not comparable to human stud¬ 
ies . 
Mechanisms for sodium retention during lithium therapy 
have not been well elucidated. Extrarenal changes in total so¬ 
dium distribution and total body water have been both docu¬ 
mented (2,14) and disputed (15) during lithium treatment, and 
while results are contradictory, it is possible that lithium- 
induced changes in these parameters form the basis for observed 
aberrations in urinary sodium excretion. It is likewise plau¬ 
sible that lithium may be causing sodium retention through an 
adrenocorticoid mediated mechanism. A decrease in pretibial e- 
dema in the nine patients previously mentioned when placed on 
spironolactone (23) suggested this possibility to the authors 
of this study (even though urinary aldosterone excretion was 
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normal). More directly, Platman et al (97) found abnormally 
elevated serum cortisol levels in 8 out of 11 patients placed 
on moderate doses or oral lithium carbonate five days before 
study and conjectured that lithium may in some way be facili¬ 
tating cortisol secretion. More recent evidence from a simi¬ 
lar study (104), however, demonstrated normal plasma cortisol 
and cortisol production rates in ten patients on chronic lith¬ 
ium therapy. Contradictory results, therefore, again make pos¬ 
itive interpretation of data impossible. A third explanation 
for abnormal sodium excretory patterns after lithium may lie 
in a direct effect of lithium on the renal tubular cell, but 
evidence in support of such a hypothesis is lacking. 
Lithium has also been found to alter potassium metabo¬ 
lism. Net urinary potassium loss has been demonstrated the 
first day after lithium ingestion in humans (3,132). A sim¬ 
ilar finding has been demonstrated only minutes after intra¬ 
venous administration of lithium chloride in anesthetized 
dogs (7,35). This study also demonstrated that when potassium 
excretion was raised to maximal levels by potassium loading 
before lithium infusion, no further rise could be elicited 
with subsequent lithium infusions, suggesting to the investi¬ 
gators that its action was occuring at a distal secretory site; 
mercurial diuretics were also able to reduce the potassium re¬ 
sponse to lithium. This series of experiments also demonstrated 
. 
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that potassium loading did not alter lithium clearance val¬ 
ues (see above). Itfis, therefore, unlikely that the mechanism 
of lithium's action resides in tubular resorption of the ion 
in exchange for potassium at a distal site. Rather, lithium's 
action here may be related to a cellular exchange of a certain 
fraction of tubular lithium and intracellular potassium, with 
gross net lithium resorption not being affected. 
Another area of considerable nephrologic interest has 
concerned the action of lithium on urinary concentrating mech¬ 
anisms. A diabetes insipidus-like syndrome in patients taking 
lithium salts was first noted in 1954 (132); subsequently, re¬ 
ports of polyuria and polydipsia as a side effect of lithium 
therapy have appeared sporadically in the psychiatric liter¬ 
ature (20,40,105,108,109), but it was not until recently that 
the entity has become well documented in careful clinical in¬ 
vestigation (1,33,34,74,120). Originally felt to be a rare 
complication of lithium therapy, Forrest et al (34), in a 
study of 96 consecutive patients treated at a large lithium 
clinic, have documented symptomatic polydipsia in 40% and poly¬ 
uria (greater than 3000 ml./day) in 12%, at a time when serum 
lithium concentrations were normal. When ten patients were 
prospectively studied before and five weeks after lithium ther¬ 
apy was begun, 70% showed significant decreases in maximum ur¬ 
inary concentrating ability (as judged by a dehydration plus 
' 
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vasopressin regimen proposed by Miller (85) ). Thus, rather 
than rare, lithium-induced concentrating defects stand as a 
most prominent side effect of lithium therapy. 
Even more striking effects on renal concentrating mech¬ 
anism have been found in animals. Large increases in urine 
volume were first noted after chronic lithium ingestion in 
dogs in 1950 (99). A. 1958 study by Schou (106) documented 
the rapid development of marked polyuria (up to 400 ml./kg./day) 
in 100% of rats receiving daily intermediate intraperitoneal 
doses of lithium chloride (3-7 meq./kg. rat body weight/day). 
Similarly, Forrest et al (34) have documented significant in¬ 
creases in rat urinary volumes only one day after 3-4 meq./ kg. 
rat body weight/day doses of intraperitoneal lithium chloride 
was begun, with daily urine output to nearly 50-70% of total 
body weight within four to five days. No similar increases 
were noted in sodium chloride injected controls. Finally, 
Harris and Jenner (52,54), working with rat in vivo vasopres¬ 
sin assays, found a significant drop in vasopressin sensiti¬ 
vity shortly after hypotonic lithium chloride administration 
was begun, and documented similar levels of inhibition at 
widely varying serum and total body lithium concentrations (53). 
There have been many recent attempts to elucidate mech¬ 
anisms for lithium induced polyuria. It has been found in hu¬ 
man studies (1,33,34,74,120), whole animal vasopressin concen- 
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trating tests (33,34,106) and in vivo rat vasopressin assays 
(52,54) that lithium induced concentrating defects are unre¬ 
sponsive to exogenous vasopressin administration (although two 
human studies (34,120) have shown submaximal vasopressin re¬ 
sponses in rare polyuria patients). That increased thirst is 
not a major factor in the effect (as was suggested by Smith et 
al (l2l) ), was successfully demonstrated by Forrest et al (34) 
who reported differences in vasopressin-stimulated concentrat¬ 
ing ability between lithium-polyuria rats and similarly poly¬ 
uria glucose-water drinking controls. Further study in humans 
(120) demonstrated normal free water clearance (thought to be 
indicative of intact function of the distal loop of Henle and 
early distal diluting segment) in these lithium polyuria pa¬ 
tients. In addition, rat (34) and dog (123) studies have shown 
normal corticopapillary gradients for sodium during lithium 
polyuria. Together these findings suggest intact function of 
the countercurrent mechanism for generating medullary hyper¬ 
tonicity in lithium-induced polyuria. Thus, the remaining 
plausible explanation for the lithium-induced defect in uri¬ 
nary concentration lies in vasopressin insensitivity at the 
distal nephron level. Forrest et al (34) has been able to show 
inhibition of urinary concentration after both vasopressin and 
dibutyryl cyclic AMP infusion into lithium rats, supporting 
such a hypothesis and suggest that lithium's action may be in- 
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hibitory at steps beyond cyclic AMP mediated distal tubular 
phenomena. 
There are pertinent toad bladder studies which both sup¬ 
port and refute such a hypothesis. Comparable to Forrest's 
in vivo finding, Harris and Jenner (54) reported inhibition 
of vasopressin and cyclic AMP stimulated water flow in toad 
urinary bladder at low serosal concentrations of lithium 
(2 meq./L.). In contrast, although Singer (120) demonstrat¬ 
ed inhibition of vasopressin-stimulated increases in both 
short circuit current and osmotic water flow at moderate 
lithium concentrations (11 meq./L.), lithium was only active 
in this way when placed on the mucosal side and, furthermore, 
the cyclic AMP stimulated increases in short circuit current 
and water flow were unaffected by the presence of lithium. 
Conflicting with both results is a report by Bentley and 
Wasserman (5), who, although demonstrating inhibition of both 
basal vasopressin and cyclic AMP stimulated short circuit cur¬ 
rent with moderate lithium concentration, found this effect 
with both mucosal and serosal lithium; furthermore, these 
authors failed to demonstrate any lithium-induced inhibition 
of vasopressin-facilitated water flow with even higher con¬ 
centrations of lithium (40 meq./L.) placed on either side of 
the membrane. Although these inconsistencies in toad bladder 
studies are not resolved, all data delineate some effect of 
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lithium on vasopressin-mediated toad bladder transport phen¬ 
omena, and, in this way support the conclusion that lithium's 
polyuric effect in vivo is caused by altered response to vaso¬ 
pressin at the distal nephron level. 
In relation to lithium's effect on the adenyl cyclase- 
cyclic AMP system, it should also be noted that this ion has 
recently been found in in vitro assay to inhibit vasopressin- 
stimulated adenyl cyclase isolated from rabbit (29) and human (27) 
kidney medullary extracts, parathyroid stimulated adenyl cyclase 
extracts from beef thyroid gland (144), and adenyl cyclase ex¬ 
tracts from brain (28) and fat cells (8), thus lending addition¬ 
al support to evidence placing its action at this biological 
site in the kidney. 
As to therapy of lithium-induced polyuria in humans, the 
only reported results (34) found vasopressin tannate in oil and 
chlorpropamide to be of no therapeutic benefit, while chlor- 
thiazide was successful in reducing urinary volume. A report 
demonstrating abolition of lithium-induced vasopressin unre¬ 
sponsiveness in toad bladders through mucosal acidification 
(to pH 5.1) (119) prompted a trial of ammonium chloride load¬ 
ing in two patients (34) but results of this attempt to control 
lithium polyuria through urinary acidification was inconclusive. 
Aside from renal concentrating defects and electrolyte ex¬ 
cretion abnormalities, nephrotoxicity with termal renal fail- 
■/ 
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ure and azotemia has been ascribed to a toxic action of lithium 
in scattered reports of fatal (16,112) or near fatal (49,125) 
lithium poisoning in humans; in the latter case renal biopsy 
suggested a direct nephrotoxic effect of lithium to the authors. 
However, the terminal illnesses of these patients make it im¬ 
possible to ascribe end stage azotemia to a direct effect of 
high serum lithium levels. In this regard animal studies are 
more relevant. Radomski (99) demonstrated gross sodium wast¬ 
ing and preterminal oliguria in previously polyuric dogs kept 
on chronic daily oral lithium carbonate administration for 12 
to 30 days, and found renal distal tubular disorganization and 
necrosis at autopsy. Similarly Schou (106) found chronic so¬ 
dium loss and preterminal oliguria and azotemia in previously 
polyuric rats at different intervals (which varied with daily 
sodium and lithium intake) after inception of chronic daily 
intraperitoneal lithium administration. In this study, severe 
proximal tubular degeneration and cellular damage occurred. 
Most recently, Evan (31), although not mentioning oliguria or 
salt loss, found in electron microscopic examination an in¬ 
creasing amount of renal tubular cell damage (primarily dis¬ 
tal) as dogs were kept on higher doses of both lithium chlor¬ 
ide and lithium carbonate for increasing periods of time. These 
data thus suggest a direct nephrotoxic effect of high doses of 
lithium, with both salt wasting and deteriorating renal func- 
) 
-17- 
tion appearing after long exposure to high serum lithium lev¬ 
els. It is impossible, however, to ascribe terminal renal 
failure and pathologic changes to a direct effect of lithium 
on the kidney, as other factors such as gross fluid and elec¬ 
trolyte imbalance were occurring in the terminal stages of 
these experiments. 
A last lithium-related nephrologic effect which has been 
reported sporadically concerns urinary acidification. In the 
only human study, l'rautner et al (88,132) demonstrated uri¬ 
nary pH elevations of one to two units one to three hours af¬ 
ter oral lithium chloride or carbonate ingestion. Good (45) 
mentioned a similar phenomenon in cats, while Orloff et al (9l) 
and Berliner et al (7), in short communications reported acute 
elevations of urinary pH and urinary bicarbonate excretion, 
with simultaneous lowering of urinary titratable acidity af¬ 
ter isotonic lithium chloride infusions in dogs. Accordingly 
Homer and Solomon (62), on the basis of stop flow experiments 
in two dogs infused with isotonic lithium chloride, concluded 
that lithium blocked normal distal urinary acidification. fhe 
quantitative aspects and the mechanism underlying the effect 
of lithium on acid excretion have not, as yet, been well defined. 
It is the purpose of the experiments presented below to eluci¬ 
date further the quantitative and mechanistic aspects for the 
inhibitory role of lithium in acid excretion. 

Experimental Method 
1. Rat Studies 
A. Acid excretion studies 
Animals utilized in all the experiments were male 
Sprague-Dawley rats weighing between 140 and 180 grams. Rats 
were caged in groups of three until the beginning of an ex¬ 
periment and allowed Purina rat chow and water ad libitum up 
until that time unless otherwise specified. At the inception 
of an experiment, rats (usually 12 in an experimental run) were 
tared and induced by mild noxious stimuli to the tail to uri¬ 
nate as completely as possible into a test tube; this urine 
was saved for later pH determinations. They were then given 
an intraperitoneal injection of the appropriate ionic solution 
(either .15 M. LiCl, .15 M. NaCl, or .15 M. KCl) at a dose rate 
of 4 meq./kg. body weight and returned to their cages. ‘One 
half hour later, they were again induced to void as complete¬ 
ly as possible into another test tube (urine was saved for 
pH determinations) and then immediately given .5 M. NH^Cl in- 
tragastrically in a dose of either 3.75 mM./kg. or 12.5 mM./kg. 
body weight. This was easily accomplished by one person by 
per orum gastric intubation with a number 6 French rubber cath¬ 
eter, while the rat was manually restrained. Following this 
procedure, rats were immediately placed into well cleaned in- 
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dividual metabolic cages in which they were allowed free ac¬ 
cess to water only. Cages were equipped to collect all voided 
urine under mineral oil; fecal contamination was prevented 
through the use of a fine wire screen placed between the rat 
and the oil. 140 minutes after introduction into the cages, 
the rats were induced to void for a third time into clean test 
tubes (for subsequent pH determinations) and were lightly an¬ 
esthetized with an intraperitoneal injection of Inactin at a 
dose of 100 mg./kg. rat body weight. 150 minutes after intro¬ 
duction into the cages, the abdominal aorta was surgically ex¬ 
posed and arterial blood was collected into heparinized glass 
syringes. One half of this sample (approximately 2 cc.) was 
transferred anaerobically to a test tube partially filled with 
mineral oil, for subsequent plasma total CO2 and lithium de¬ 
terminations, while the other half was left in the stoppered 
glass syringe, for subsequent arterial blood gas and pH deter¬ 
minations. Immediately thereafter any residual urine remain¬ 
ing in the bladder was drawn anaerobically into a tuberculin 
syringe and added to the urine collected in the metabolic cages. 
Urine collected at 140 minutes was also added to this amount 
after its pH was determined. The total collection was mea¬ 
sured for volume; a portion saved under oil for subsequent 
total (X^, electrolyte, and lithium determinations, while the 
remainder was dilutee! 1:25 with water for subsequent titratable 
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acidity and ammonia determinations. 
Because of instability of all urinary acid parameters re¬ 
gardless of method of preservation (89), urinary pH determin¬ 
ations were performed within 30 minutes of urine collection. 
Titratable acid and ammonia determination were commenced with¬ 
in one hour of the completion of the final urine collection. 
In addition, because of slow but definite loss of CO2 into the 
oil phase of the anaerobically collected urine and plasma sam¬ 
ples, total CO2 determinations were performed within four hours 
of collection. 
B. Hematocrit study 
18 male Sprague-Dawley rats between 140 and 160 grams 
were fed Purina rat chow and water ad libitum. At the begin¬ 
ning of the experiment, animals were randomly divided into three 
groups and tail vein blood was collected into heparinized micro¬ 
hematocrit tubes. Hats were then given intraperitoneal injec¬ 
tions of either .15 M. LiCl, .15 M. NaCl, or .15 M. KC1 at a dose 
rate of 4 meq./kg. body weight. 30 minutes later .5 M. NH4CI, 
in a dose of 3.75 mM./kg. body weight, was given intragastric- 
ally. 60 minutes later an additional sample of tail vein blood 
was collected into hematocrit tubes and rats were exsanguinated 
via abdominal aorta. 
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C. Electrolyte balance study 
18 Sprague-uawley male rats between 140 and 160 grams 
were randomly divided into two groups, paired for weight, and 
placed into individual metabolic cages, equipped for urine 
collection. Free access to water was allowed. The experiment¬ 
al group was allowed up to 12 grams per day of laboratory pre¬ 
pared rat food (containing per kg. diet 470 g. sugar, 300 g. 
casein, 100 g. lard, 50 g. corn oil, 6.1 g. NaCl, 11.6 g. 
i^HPO^, 50 g. vitamin-mineral mix) while each pair mate was 
allowed the same amount of food on the subsequent day. After 
two days of pair feeding, experimental rats were started on 
daily intraperitoneal doses of .15 M. LiCl at a dose rate 
of 4 meq./kg. rat bosy weight. Control rats received no in¬ 
jection. rTats were weighed daily and dosages were adjusted 
accordingly. The first urinary collection period extended 
for the 2% hours after the first lithium dose, at which time 
urine funnels were emptied; the second urine collection per¬ 
iod lasted 21^ hours; all subsequent urinary collection per¬ 
iods lasted 24 hours. Urine volumes were measured daily and 
aliquots of urine were frozen for subsequent electrolyte and 
lithium determinations. The experiment was terminated after 
the fifth 24 hour urine collection was completed, at a time 
when mean daily urinary volume was still rising. 
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II. Human Studies 
Four healthy male volunteers and one psychiatric male in¬ 
patient judged to be manic depressive were involved in this 
pilot study of the effects of lithium administration on acid 
excretion in the human. Acid excretion was evaluated in each 
patient before lithium treatment and following a single oral 
dose of lithium, using a short acid excretion test described 
by Wrong and Davies (146). Subjects were allowed free access 
to food and water before and during the test. On the morning 
of the pre-lithium test, subjects emptied their bladders com¬ 
pletely. Thenceforth, urine was collected hourly with a small 
amount of thymol as a preservative, and measured for volume 
and pH; a small aliquot was immediately frozen for subsequent 
titratable acidity and ammonia determinations. After the first 
baseline urine collection, a single tube of venous blood was 
drawn for serum total CO2 determination. Subjects then swal¬ 
lowed a pre-determined number of 250 mg. uncoated NH^Cl tab¬ 
lets (Lilly) over a 15-20 minute period at a dose rate of 
.1 g./kg. body weight. One additional venous blood was ob¬ 
tained for serum total CO2 determination two hours after the 
NH^Cl ingestion and the test was terminated three hours later. 
On the day of the post-lithium test, a similar protocol 
was followed except that two hours before the NH^Cl dose was 
administered, the subject ingested Li+ at a dose rate of 
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28 meq./70 kg. body weight. In three cases this dose was 
in the form of uncoated lithium carbonate tablets while in 
two cases the dose was in the form of uncoated lithium chlor¬ 
ide tablets. Again, blood was drawn at zero and two hours 
after ammonium chloride ingestion, this time for serum lith¬ 
ium as well as for CC^ determination. 
Determinations 
Urinary volume determinations were made with volumetric 
urine collection test tubes with an accuracy of -.1 ml. U- 
rinary pH determinations were made using a Leeds-Northrup pH 
meter with an external calomel reference electrode and a glass 
reading electrode which read pH accurately in samples as small 
as .2 cc. All determinations were done in duplicate, with 
variance of less than +.2 pH units. 
I’itratable acidity was determined by diluting between 
.2 and .5 cc. of urine in 25 cc. of distilled water, adding 
.5 cc. of phenolsulfonthalein (6 mg./ml.) as an indicator and 
titrating with approximately .01 N. NaOH to pH 7.4 (115). The 
titrating solution was standardized at each run with prestand¬ 
ardized .01 N. HC1. Titrations were done in duplicate, to an 
accuracy of -.01 ml. and results were expressed as meq./ kg. 
rat/collection time by multiplying resultant concentrations by 
urinary volume/collection time/kg. rat. 
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Urinary ammonia was determined using a standard Conway 
microdiffusion technique (13) in which ammonia was released 
with saturated K2CO3 from 1 ml. of 1:25 dilution of urine placed 
in the outer rim of a sealed Conway dish. The resultant free 
ammonia diffused into 1% boric acid-Conway indicator placed 
in the center of the dish. This was back-titrated with pre¬ 
standardized .02 N. HC1. Determinations were done in duplicate 
to an accuracy of ^.01 ml., and results were expressed as 
meq./kg. rat/collection time by multiplying resultant concen¬ 
tration times urinary volume/collection time/kg. rat. 
Urinary and plasma total CO2 values were obtained from 
Van Slyke gasometric analysis (136) on .1 cc. samples taken 
from under oil. Determinations were done in duplicate in most 
instances, to an accuracy of ±.5 meq., and results were ex¬ 
pressed as meq./L. Serum bicarbonate concentration was de¬ 
termined by subtracting millimolar concentrations of pC02 de¬ 
termined on arterial blood gas samples. 
In human experiments, serum total CO2 values were deter¬ 
mined by the Yale-New Haven Hospital Clinical Chemistry Lab¬ 
oratories . 
Total acid excretion was calculated as excretion of ti- 
tratable acid plus ammonia minus bicarbonate. Urinary bicar¬ 
bonates were run only if urinary pH was greater than 6.25, as 
negligible values for bicarbonate excretion would be predicted 
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by the Henderson Hasselbach equation, using a UpC02 f°r 
urines whose pH was less than this amount (pCC^ values exceed¬ 
ing this amount have not been demonstrated in urines within 
this acid pH range (26) ). 
Arterial blood pH and pCC^ were determined by the Yale- 
New Haven Hospital blood gas laboratory, using an \strup Ra¬ 
diometer fitted with a micro-glass pH electrode and a silicon 
membrane pCC>2 electrode. 
Urinary and serum sodium and potassium values were deter¬ 
mined in duplicate in appropriately diluted samples using flame 
photometry with an internal lithium standard. Urinary and se¬ 
rum lithium values were determined in duplicate using atomic 
absorption spectrophotometry. 
Tail vein bloods collected in heparinized hematocrit tubes 
were spun at 3,000 r.p.m./min. for 3 minutes. Hematocrits 
were read to the nearest .5 per cent. 
Statistical significance in the rat experiments was assessed 
by a non-paired Student's t test; in human experiments a paired 
Student's t test was used. Statistical confidence was estab¬ 
lished at the p .05 confidence limit. All results are expressed 
as means - standard error of the mean. 
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Results 
1. Rat Studies 
A. Acid excretion studies 
The acute effect of lithium chloride injection upon 
the rat's ability to excrete acid was compared to that of so¬ 
dium chloride and potassium chloride in the first animal ex¬ 
periments describee1 above. Two dosage levels of ammonium 
chloride were utilized, 3.75 m/i./kg and 12.7 5 mM./kg., to in¬ 
duce both moderate and severe metabolic acidosis respectively 
(potassium chloride injected animals were studied during mod¬ 
erate acidosis only). The time course, urinary pH, and re¬ 
lated data for the moderate acidosis experiments are shown in 
figure 1 and table 1. It is evident that although the three 
groups of animals are all excreting urine of similar pH before 
ionic injection (pH 6.6), the urinary pH of the lithium group 
dramatically diverges from that of the other two groups one 
half hour after the injections are given, changing from 
6.59^.14 to 7.99ll.49, while urinary pH values in the other 
two groups are not significantly altered. That this response 
is not due to lithium induced metabolic alkalosis was shown in 
a separate experiment in which arterial blood pH values were 
found to be normal (mean = 7.36-.03) in a group of six rats 
30 minutes after intraperitoneal lithium injection at a dose 
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of 4 meq./kg. Moreover, 150 minutes following this point, 
during which moderate metabolic acidosis was developing sec¬ 
ondary to NH^Cl ingestion in all the groups, the lithium group, 
although demonstrating some relative urinary acidification, 
failed to lower its urinary pH below that of arterial blood 
(urinary pH = 7.32^1.2, while arterial blood pH = 7.21^.02). 
At this point, both NaCl and K.C1 injected animals showed marked 
responses to the ingested acid load, with urinary pH of the 
former falling to 5.80^.05 and the latter to 5.97^.07. The 
difference in these two values was significant at the .05 level. 
That true metabolic acidosis had been achieved in all 
groups at 180 minutes can be seen from the plasma HCO^” and 
arterial pH data of table 1, where it is noted that the lith¬ 
ium group exhibited the most severe acidosis, the sodium group 
exhibited the least severe acidosis, and the potassium fell in 
between the two. differences in levels of acidosis among the 
groups also serve to elucidate the relationship between urinary 
responses of each group to ongoing acidosis. Thus, in a plot 
of urinary pH at 180 minutes vs. plasma bicarbonate (figure 2) 
it becomes clear that while the sodium group was responding to 
a slightly decreased plasma bicarbonate with an acid urine, the 
lithium group was responding to even lower levels of plasma 
bicarbonate with an inappropriately alkaline urine. Again in 
this figure, potassium chloride had an intermediary effect, 
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resulting in an acid urine at bicarbonate levels in between 
that of lithium and sodium. 
Examination of other urinary parameters is in direct ac¬ 
cord with the above results (table 1). Thus in the lithium 
group both titratable acid and ammonia are markedly decreased 
when comoared to the other rwo groups, even though it is ex- 
hibiting the most severe metabolic acidosis; the sodium group 
demonstrated significantly greater excretion of titratable 
acidity and ammonia, while the potassium group, though ex¬ 
creting far more ammonia and titratable acidity then the 
lithium group, was unable to excrete ammonia as well as the 
sodium group (p .02). When total acid excretion, taken as 
the sum of titratable acid and ammonia minus bicarbonate 
excretion is studied, it is seen that the lithium group is 
least able to excrete the acid load, the potassium group as¬ 
sumes an intermediary potsition, and the sodium group demon¬ 
strates the greatest ability to excrete "he acid load. 
An additional finding which must be noted in the data of 
table 1 is the striking elevation of urinary volume in the po¬ 
tassium injected group when compared to the other two groups; 
V/2^ hr./kg. of the potassium group was 2%-3 times higher than 
that of the lithium or sodium groups, which demonstrated com¬ 
parable values. Data for the potassium group represent the 
means from three separate experiments, all of which demon- 
. 
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strated increased urinary volume 
Having demonstrated an impressive defect in the excre¬ 
tion of a moderate acid load in lithium versus sodium or po¬ 
tassium injected rats, it was felt desirable to study acid 
excretion under more severely acidotic conditions in an ef¬ 
fort to observe whether marked lowering of filtered bicar¬ 
bonate will accentuate the inhibitory effect of lithium on 
acid excretion. In these experiments only sodium injected 
animals were used as controls. lhe time course and urinary 
pH data for these experiments appears in figure 3, while a 
summary of the remaining relevant data appears in table 2. 
the marked increase in urinary pH one half hour after lithium 
injection is again evident, but in contrast to the moderate 
acidosis induced 150 minutes after 3.75 mM./kg. intragastric 
NH^Cl, 150 minutes after 12.5 mM./kg. of intragastric NH^Cl 
a severe acidosis was induced, with plasma bicarbonate val¬ 
ues clustering at about 8.5 meq./L. and arterial blood pH 
clustering at about 7.04 for both grouns, with no statisti¬ 
cal significance between them. In contrast to moderately 
acidotic conditions, severe acidosis produced a marked de¬ 
crease in urinary pH in the lithium group from pre-acid con¬ 
ditions (from 8.23^.10 to 6.16^.17); likewise, sodium in¬ 
jected animals demonstrated a brisk decrease in urinary pH 
(from 6.65-.062 to 5.64-.06). Although statistical difference 
' 
-30- 
between the two groups was achieved, it is apparent from 
figure 4 that in the very low plasma bicarbonate ranges, a 
few lithium animals closely approximate the minimal urinary 
pH exhibited in the sodium group. When excretion of titra- 
table acidity, ammonia, and total acidity are studied, how¬ 
ever (table 2), it is seen that there is still a large def¬ 
icit in excretion of the acid load in the lithium injected 
group. 
It is apparent from the above data that while lithium 
injection effectively blocks acid excretion, this inhibition 
is not absolute. Thus figure 5 illustrates that, similar to 
sodium injected animals, total acid excretion of the lithium in¬ 
jected group is significantly higher in severely acid animals 
than in moderately acidotic ones. This reflects significant 
enhancement of titratable acidity and ammonia excretion in 
both groups when more severe acidosis is imposed. Thus, the 
lithium-injected group, while impaired in acid excretion at 
all levels of acidosis, is able, like the sodium group, to 
vary its response appropriately with varying acid-base condi¬ 
tions. 
B. Hematocrit study 
This study was carried out to assess degrees of volume 
expansion in the sodium, potassium, and lithium injected animals 
3 '• 
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during the moderate acidosis experiments. As describee! in 
Experimental Methods, hematocrits were compared in rats at 
the beginning and 90 minutes after experimental inception; 
results are illustrated in figure 6. It can be seen that, 
although mean baseline hematocrits for each group were sim¬ 
ilar, 90 minutes later the lithium group demonstrated less 
hematocrit drop than either the sodium or potassium groups, 
which demonstrated similar depressions. The lithium group 
appears, therefore, to be the least volume expanded of the 
three groups, with both the sodium and potassium groups being 
equally more volume expanded. 
C. Electrolyte balance studies 
In an effort to relate acid excretory defects in 
lithium treated rats to other secretory or resorptive tu¬ 
bular defects, patterns of electrolyte excretion were studied 
both in the acute 2\ hour moderate acid loading model, and in 
a chronic rat balance study. In the former, two sets of pre¬ 
conditions were employed: in certain experimental runs, rats 
were allowed ad libitum Purina rat chow and water until the 
inception of the experiment, while in the others, rats were 
grouped carefully for weight and allowed Purina rat chow at a 
rate of 12 g./l50 g. rat plus water ad libitum for 3 days before 
experimental inception. i'hus the former groups of rats had 
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varying electrolyte intakes, while the latter had identical 
electrolyte intakes. Results for lithium and sodium injected 
groups appear in table 3, where it can be seen that in the e- 
lectrolyte unbalanced studies there is no statistical differ¬ 
ence in sodium or" potassium excretion between the sodium and 
lithium injected group of rats. in the balanced experiments, 
both sodium and potassium excretion were elevated in the lith¬ 
ium over sodium injected animals (although not significant¬ 
ly so). 
In accord with the results of the latter experiments 
are the results of the chronic balance experiment performed 
with pair fed rats. In this experiment, the first collection 
ended 2% hours af^er lithium was injected into the experimental 
rats in order to make conditions comparable to the rat short 
acid excretion model used above. In this experiment, control 
rats received no sodium injection and there was no NH^Cl intuba¬ 
tion, however. Results for sodium, expressed as mean sodium excre¬ 
tion of the lithium injected animals minus mean socium excre¬ 
tion of the pair fed control, appears on figure 7, while po¬ 
tassium data appears in figure 8. It can be seen that in the 
first 2h hours following the first lithium injection there is 
significant sodium and potassium loss in the experimental ani¬ 
mals as compared with their controls. while experimental con- 
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ditions are not exactly similar to the balanced short acid ex¬ 
cretion rat model studies, they support the findings in those 
experiments that lithium injection acutely causes increased so¬ 
dium and potassium excretion. 
The remainder of the experiment, designed to monitor so¬ 
dium and potassium balance as lithium polyuria was induced, 
indicates similar excretion patterns for sodium and potassi¬ 
um during this period, with early net sodium and potassium re¬ 
tention (day 1 and 2) in experimental versus control groups, 
followed by impressive net loss of urinary sodium and potas¬ 
sium as polyuria becomes more profound (day 3-6). It may al¬ 
so be seen that, although not reflected in the first 2% hour 
period (in accordance with the rat short acid excretion model), 
significant rises in urinary volume occur in the lithium group 
with the first 24 hour period. 
11. Human Studies 
A short acid excretion test was utilized to illustrate the 
effect of lithium on acid excretion in humans. Results of the 
urinary pH data for the pre- and post-lithium test appear in 
figure 9. It can be seen that there is no apparent rise in 
urinary pH over baseline values two hours after oral ingestion 
of 28 meq. Li+/70kg. At this time, NH4CI at .lg./kg body 
weight, was given orally in an effort to induce metabolic acido- 
. 
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sis. It can be seen that I, 2, and 3 hours after ammonium 
chloride ingestion, when there was significant lowering of 
the serum bicarbonate, subjects in the post-lithium test ex¬ 
hibited a blunted urinary pH response to the acid load which 
was statistically significant when compared to the pre-lithium 
test. Titratable acid and ammonia excretory rates, however, 
did not indicate an impaired acid excretory rate at any time 
in the post-lithium test, suggesting an absence of inhibition 
of acid excretion at this level of lithium dosage. 
■ 
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Discussion 
1. Rat Studies 
A. Acid excretion studies 
ihe objective of the rat experiments described above 
was to determine the effect of rapid parenteral administra¬ 
tion of lithium chloride on the ability of the rat kidney 
to acidify the urine. responses were compared to those of 
animals similarly injected with both potassium and sodium 
chloride. .Net acidification of the urine was monitored 
through measurement of urinary pH and urinary bicarbonate, 
titratable acid, and ammonium excretion, ail of which are 
presently thought to be dependent on active hydrogen ion 
secretion in both the proximal and distal nephron (81,100). 
Ammonium chloride loading was employed to maximize small 
differences in the groups' abilities to both lower urinary 
pH and excrete net acid (taken as titratable acid + ammonium 
bicarbonate excretion). An acute (2k hour) protocol was 
chosen to minimize sicie effects of chronic ion ingestion 
which may alter acid excretory ability (eg. impaired concen¬ 
trating ability (24), reduced glomerular filtration rate (95) 
altered adrenal activity (73), or elevated renal glutaminase 
activity (93),.). 
It was clear that under the conditions imposed in the ex 
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periments lithium chloride profoundly inhibited urinary acidi¬ 
fication in relation to the other two ions. As all animals 
within an experiment were subjected to the same metabolic loads 
of acid, it may be inferred that differences among the groups 
with respect to plasma bicarbonate and total acid excretion 
were due to differences in hydrogen ion secretory rates within 
the tubule. At the end of the moderate acidosis experiments, 
the lithium group demonstrated the lowest and the potassium 
group the highest serum bicarbonate levels and total acid ex¬ 
cretion, reflecting respective rates of renal hydrogen ion se¬ 
cretion; values for both parameters in the potassium-injected 
group were intermediate, probably reflecting an intermediate 
rate of hydrogen ion secretion (although plasma bicarbonate in 
this group may also have been lowered by extrarenal hydrogen 
ion shifts (43,126) ). Similarly plasma bicarbonates of the 
lithium-injected group tended to be higher than the sodium 
group in the severe acidosis experiment (although statistical 
significance was not achieved), while total acid excretion was 
decidedly lower in the former group, again reflecting lower 
hydrogen ion secretory rates in the lithium animals. 
In analyzing the results of the rat acid excretion studies 
an attempt was made to identify what known determinant of renal 
acid excretion lithium might be affecting. The following fact¬ 
ors were considered: 1) carbonic anhydrase activity; 2) extra- 
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cellular volume expansion; 3) renal intracellular acid-base 
status; 4) intratubular electrochemical gradients; and 5) cou¬ 
pled luminal sodium-hydrogen ion exchange. 
Diminishment of renal carbonic anhydrase actibity is a 
phenomenon known to cause decreased urinary acidification 
through enhancement of proximal and distal tubular disequil¬ 
ibrium pH's (80,102,137). An effect of lithium on this enzyme 
seems unlikely in light of the data demonstrating absence of 
such lithium induced effect on red cell carbonic anhydrase ac¬ 
tivity. 
Extracellular volume expansion is another factor which 
exerts an inhibitory effect on acid excretion (70,71,98). In 
an effort to separate out a direct effect of lithium exclusive 
of any effects of extracellular volume, (a factor not controlled 
for in the studies of Orloff et al (91) or Berliner et al (7l) ) 
acid excretion in lithium treated animals was compared to that 
in sodium injected controls. As data from the hematocrit stud¬ 
ies illustrate, lithium treated animals in the course of the 
acid ecretion studies are less volume expanded than sodium treat¬ 
ed animals. Yet total acid excretion in the lithium treated 
group is significantly below the sodium treated group. It is 
suggested, therefore, that the acid inhibitory effect of lithium 
is mediated through factors other than volume expansion. 
Intracellular pH is also felt to be of importance in de- 

-38- 
termining acid excretory ability, through a regulatory action 
on tubular hydrogen ion transport rates (80,81). Although it 
is presently little more than conjecture, it is conceivable 
that lithium, as an ion which is accumulated intracellularly, 
may replace a portion of the hydrogen ion pool, thereby caus¬ 
ing intracellular alkalosis and secondary depression of hydro¬ 
gen ion secretion. 
Alteration of intratubular electrochemical gradients is a 
fourth means through which intratubular hydrogen ion secretory 
rates may be altered. Lithium is an ion which is probably not 
resorbed distally (see introduction) and it may, therefore, be 
concentrated in this location within the tubule, thereby in¬ 
creasing intratubular electropositivity. Such an alteration 
would increase the electrochemical gradient against which hy¬ 
drogen ion must be secreted, and may underly the depressed hy¬ 
drogen ion secretory rates seen after lithium administration. 
Lastly, coupled luminal sodium-hydrogen ion exchange is 
also felt to be important in at least a nonspecific way in 
regulating hydrogen ion secretion (81,94,103). Competitive 
or non-competitive inhibition between lithium and sodium for 
such coupled hydrogen ion movement may act to depress hydrogen 
ion secretion. This mechanism seems particularly plausible in 
light of the possible common pathways of tubular transport of 
sodium and lithium (see introduction) and it is strengthened by 
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the data presented in the present experiments suggesting in¬ 
creased sodium excretion during periods of decreased urinary 
acidification. 
It is also of interest to speculate about the location of 
lithium's action within the tubule. A plot of urinary pH ver¬ 
sus serum bicarbonate compiled from both moderate and severe a- 
cidosis experiments (figure 10) reveals that at very low serum 
bicarbonate levels urinary pH in the lithium animals approaches 
the limits reached by the sodium controls. Such a pattern of 
decreasing urinary pH only at very low levels of plasma bicar¬ 
bonate is also seen in proximal renal tubular acidosis in hu¬ 
mans (86), where steep hydrogen ion gradients are generated 
only when a proximal tubular bicarbonate "leak" is minimized 
by decreasing the filtered bicarbonate load. The similarity 
in acid excretory patterns between the present studies and 
human proximal renal tubular acidosis allows the conjecture 
that the action of lithium in inhibiting acid excretion may 
reside, in part, within the proximal tubule. The data do not, 
however, exclude an additional distal tubular acidification 
defect. 
In agreement with previous studies (9,38,75,90,101,103,143), 
the present experiments have also confirmed that administration 
of acute loads of potassium ion also inhibits urinary acidifi¬ 
cation (although not nearly to the extent of the lithium 
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ion). This phenomenon, originally felt to be due to compe¬ 
tition between potassium and hydrogen for secretion at the 
distal tubule level (6,38,90), it presently felt by some to 
be due to a potassium-induced intracellular alkalosis of the 
renal tubular cell (100), with secondary depression of hydro¬ 
gen ion secretion throughout the nephron. Recent experi¬ 
ments, however, in which volume expansion was carefully con¬ 
trolled for (12,72), have concluded that most of the inhibi¬ 
tory effect of intravenous potassium administration is due 
to this effect rather than a specific effect of potassium 
ion on hydrogen ion secretory mechanism. The present experi¬ 
ments, by demonstrating relative inhibition of acid excretion 
in potassium versus sodium-injected groups (which were volume 
expanded to the same degree), support the supposition that 
at least part of the inhibitory effect of potassium infusion 
on acid excretion is due to factors other than volume expan¬ 
sion, and thus lend additional support to the hypothesis 
that potassium-induced inhibition of acid excretion occurs 
at the renal cellular level. 
3. Electrolyte excretion studies 
Results of the chronic acid excretion studies sug¬ 
gest that lithium administration stimulates both sodium and 
potassium excretion in the hours after its administration. 
. 
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Increasec- sodium excretion induced by lithium administra¬ 
tion is also suggested in the 2k hour controlled diet a- 
cid excretion studies, in which sodium excretion in the 
lithium-injected group was comparable to that in the so¬ 
dium-injected group, in which sodium excretion was prob¬ 
ably elevated by virtue of the sodium injection. ihat 
potassium excretion was not shown to be significantly el¬ 
evated in lithium treated animals in these studies may 
have been related to increased distal sodium loads caus¬ 
ing supranormal potassium secretion in the sodium treated 
group; in this regard the paired balance study, in which 
lithium-injected animals are compared to untreated con¬ 
trols, is probably more valid an estimate of the effect 
of parenteral lithium on potassium excretion. Previous 
studies documenting increased, potassium excretion shortly 
after infusion of lithium chloride was begun also support 
this conclusion (3,7,35,132). 
As was mentioned above, enhanced sodium excretion in the 
first 2k hours after lithium administration may be related to 
depression of sodium-hydrogen ion exchange thought to be of im¬ 
portance in urinary acidification (94,100). Increased potas¬ 
sium excretion may arise from increased distal sodium-potassium 
exchange which results from increased distal loads of sodiun. 
■ 
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l'his is not to imply that a direct reciprocal relationship 
between hydrogen ion and potassium ion secretion underlies 
this increased potassium excretion. Such a relationship has 
recently been shown not to exist (79). It is of interest to 
note that sodium and potassium wasting has also been noted 
in human poximal and distal renal tubular acidosis (44,86, 
113), with similar mechanisms suggested to explain the pheno¬ 
mena . 
In the chronic balance study, striking chronic increases 
in levels of both sodium and potassium excretion was noted short¬ 
ly after an in itia1 period of sodium and potassium retention 
(excluding the first hours of the study). This initial 
retentive pattern for sodium is quite similar to that described 
in previously in humans after oral lithium ingestion (3,63,87 
132,133) (see introduction); potassium retention has, however, 
not been previously documented. Explanation for these initial 
retentive patterns are not readily apparent. The chronic daily 
sodium losses accompanying lithium administration have also been 
described in previous studies (99,106) and have been attributed to 
direct lithium toxicity at the tubular level. while this is a dis¬ 
tinct possibility, both sodium am1 potassium loss may in addition be 
caused by chronically induced renal acidification defects (see a- 
bove) which may attend chronic lithium administration. 
i’hat polyuria in the lithium animals increases strikingly 
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at a time when sodium and potassium wasting become profound 
could also suggest electrolyte loss secondary to the lithium- 
induced vasopressin-sensitive diabetes insipidus. Studies of 
electrolyte excretion patterns in both hereditary (51,135) and 
surgical (37) hypothalamic diabetes insipidus have, however, 
suggested only moderate potassium depletion with normal con¬ 
servation of sodium. it would seen unlikely that these losses 
are due entirely to vasopressin-insensitive diabetes insipidus. 
Contrawise, however, it may be postulated that the chronic 
losses of sodium and potassium contribute to lithium polyuria 
and the lithium induced concentrating defect. fhis interpre¬ 
tation is especially appealing in light of the well-known vaso¬ 
pressin-insensitive concentrating defect caused by potassium (61). 
However, in light of previous work demonstrating disrupted cor- 
ticopapillary gradients in states of hypokalemic nephropathy 
(82), studies demonstrating intact corticonapillary gradients 
for sodium in lithium polyuric rats (34) make this unlikely. 
However, existing studies do not conclusively rule out vasopressin- 
insensitivity at the collecting duct level as additional cause for 
hypokalemic concentrating defects (60), and, with regard to the 
present studies showing decided potassium loss as polyuria in¬ 
creases, hypokalemic nephropathy can, at present not be en¬ 
tirely excluded as contributing to lithium polyuria. 
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II. Human Studies 
The human studies, although showing differences in urinary 
pH attained after ammonium chloride loading in the post lithi¬ 
um experiments, failed to demonstrate significant differences 
in ammonium or titratable acid excretory rates. However, it 
may be noted that serum lithium levels averaged only .87 meq./L. 
midway through the experiment, a level significantly lower than 
that attained in the rat experiments (approximately 2.5 meq./L. 
at 2% hours). It is of additional note in that the demonstra¬ 
tion of urinary pH elevation in the post lithium experiments 
without depressions in ammonium or titratable acid excretory 
rates may, in part, be due to the greater sensitivity of the 
former determinations. Thus, although an acid excretory de¬ 
fect was not conclusively demonstrated in humans, it is felt 
that one may still occur at higher levels of lithium intoxica¬ 
tion. 
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Summary 
Experiments were designed to detect acid excretory de¬ 
fects in rats and humans after acute administration of ionic 
lithium. 2\ hours after intraperitoneal injection of .15 M. 
lithium chloride (4 meq./kg. rat body weight), during which 
ongoing metabolic acidosis had been induced with oral ammoni¬ 
um chloride, lithium-injected rats demonstrated strikingly 
increased urinary pH and bicarbonate excretion, and decreased 
ammonium and titratable acid excretion, in comparison to both 
sodium and potassium-injected rats. Potassium-injected ani¬ 
mals demonstrated a much less striking relative acidification 
defect in relation to sodium-injected animals. Human studies 
designed to detect a similar acid excretory defect failed to 
do so; serum lithium levels, however, were significantly low¬ 
er than those in the rat studies. 
Electrolyte excretion during the 2% hours of the experi¬ 
ment revealed significantly increased excretion of sodium in 
the lithium treated as compared with the sodium treated con¬ 
trols. Studies designed specifically to detect lithium-induced 
electrolyte excretion abnormalities demonstrated increased ex¬ 
cretion of both sodium and potassium in the 2% hours following 
.15 M. lithium chloride injection (4 meq./kg.), when compared 
to pair fed controls receiving no ionic injection, and further 
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demonstrated striking losses of both sodium and potassium when 
daily injection were carried out over a six day period. 
It was concluded that ionic lithium, at proper dosages, 
caused a marked retardation of acid excretion in rats at a time 
when sodium and potassium excretion is elevated. An inhibi¬ 
tion of coupled luminal hydrogen-sodium ion exchange within 
the proximal tubule is the underlying mechanism suggested by 
the present data. 
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Appendix B 

URINE COLLECTION PERIOD 
Figure 1. Time course ami urinary pH data during; induction of mod 
erate acidosis with 3.75 mM intragastric NH4CI, in lithium, sodium 
and potassium chloride injected animals (4 meq./kg.). Brackets in 
dicate 1 S. E. m equals the number of rats per group. 
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PLASMA HC03” (mEq/L), 2.5 hrs. after 3.75 mM NH4CI/kg 
Figure 2. The effect of plasma bicarbonate alterations (induced 
with 3.75 mM./kg. intragastric NH4CI) on urinary pH in lithium, 
sodium, and potassium chloride injected animals (4 meq./kg.). 
Figures in parentheses indicate number of rats per group. 

URINE COLLECTION PERIOD 
MINUTES AFTER ION ADMINISTRATION 
Fieure 3 Time course and urinary pH data during induction of 
vere acidosis with 12.5 mM./kg. intragastric MH4CI in lithium 
sodium injected animals (4 meq./kg.). Brackets indicate - S. 
n equals number of rats per group. 
se¬ 
am I 
E. 

UpH 
at 
180 min 
PLASMA HCO3- (mE<l/L). 2.5 hrs. after 12.5 mM/kg 
Figure 4. The effect of plasma bicarbonate alterations (induced 
with l2. 5 m;vi./kg. intragastric NHaCI) on urinary pH in lithium and 
sodium chloride injected animals (A meq./kg.). Figures in paren¬ 
theses indicate number of rats per group. 

Total Acid 
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per kg 
| | Moderate Acidosis, PHCq “ mEq/L 
3 
Y//A Severe Acidosis, PHCO3 “ 8“9 mEq/L 
Li Cl groups 
p <. 005 
NaCI groups 
p <.005 
Figure 5. Acid excretory response of lithium and sodium chloride 
injected animals (4 meq./kg.) to moderate and severe metabolic acid¬ 
osis (induced with 3.75 and+l2.5 mM./kg. intragastric NH4CI, respect 
ively). Brackets indicate - S. E. Figures in parentheses indicate 
number of rats per group. 

Before Injection 90 Minutes After Injection 
LiCI vs NaCI - N.S. 
LiCI vs KCI - N.S. 
NaCI vs KCI - N.S. 
LiCI vs NaCI p< 005 
LiCI vs KCI p< .005 
NaCI vs KCI N.S. 
Figure 6. Comparison of hematocrits before and 90 minutes after 
injections of lithium, potassium, and sodium chloride (4 meq./kg.) 
(60 minutes after 3.7 5 mM./kg. intragastric N^Cl), Brackets in¬ 
dicate t S. n. Figures in parentheses indicate number of rats per 
group. 

100 
50 
Urine 
Volume 
ml/24 hrs 
Figure 7. Comparison of urinary volumes and sodium excretion be-^ 
tween animals receiving daily lithium chloride injections (4 meq./kg.) 
and uninjected controls. Brackets indicate - 3. E. tigures in par¬ 
entheses indicate number of rats studied per day. 

COLLECTION PERIOD (Hrs) 
Urine 
Volume 
ml/24 hrs 
figure 8. Comparison of urinary volumes and potassium excretion 
between animals receiving daily lithium chloride injections 
(4 meq./kg.) and uninjected controls. Brackets indicate ± 3.E. 
Figures in parentheses indicate number of rats studied per day. 

u pH 
• 5 Subjects, Pre-Lithium 
0—0 Same Subjects Following Single 
Oral Dose Of Lithium 
HRS AFTER NH4CI, 0.1 g/Kg 
Figure 9. Urinary pH response in human subjects to p.o. NH^Cl 
(.1 g./kg.) before and after ingestion of lithium (28 meq./70 kg. 
Brackets indicate ± S. E. 

PLASMA HCO3- (mEq/L) 
Figure 10. Correlation of urinary pH and plasma bicarbonate in lith 
ium and sodium chloride injected rats (data compiled from moderate 
and severe acidosis experiments), n equals the number of rats per 
group. For the LiCl injected group r-,8507, p<.001; for the NaCl 
injected group r=.4634, p<.02. 
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